Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


KLEMP WALTER V Create: Alert

All | News | Filings
Date FiledTypeDescription
07/13/2023 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Paid exercise price by delivering 3,216 shares @ $0.5903, valued at $1.9k
Exercised 13,204 restricted stock units @ $0
07/05/2023 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Paid exercise price by delivering 3,584 shares @ $0.5788, valued at $2.1k
Exercised 14,717 restricted stock units @ $0
11/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/15/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/15/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/12/2021 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Paid exercise price by delivering 3,215 shares @ $3.56, valued at $11.4k
Exercised 13,205 restricted stock units @ $0
07/06/2021 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Paid exercise price by delivering 3,584 shares @ $3.56, valued at $12.8k
Exercised 14,718 restricted stock units @ $0
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/12/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/12/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/15/2019 4/A KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 500,000 options to buy @ $1.82, valued at $910k
07/15/2019 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 500,000 options to buy @ $1.31, valued at $655k
Granted 316,907 restricted stock units @ $0
07/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2019 3 KLEMP WALTER V (Director) has filed a Form 3 on Soliton, Inc.
06/08/2018 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 603,000 options to buy @ $1.82, valued at $1.1M
08/18/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/07/2016 3 Form 3 - Initial statement of beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy